337 related articles for article (PubMed ID: 28174399)
41. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
42. Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction.
Nagami Y; Ominami M; Otani K; Hosomi S; Tanaka F; Taira K; Kamata N; Yamagami H; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y
Digestion; 2018; 97(1):38-44. PubMed ID: 29393168
[TBL] [Abstract][Full Text] [Related]
43. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction (Br J Surg 2013; 100: 1050-1054).
Polkowski WP; van Lanschot JJ
Br J Surg; 2014 May; 101(6):735. PubMed ID: 24723025
[No Abstract] [Full Text] [Related]
44. What Is the Best Operation for Proximal Gastric Cancer and Distal Esophageal Cancer?
Mazer LM; Poultsides GA
Surg Clin North Am; 2019 Jun; 99(3):457-469. PubMed ID: 31047035
[TBL] [Abstract][Full Text] [Related]
45. Surgical strategies for adenocarcinoma of the esophagogastric junction.
Schiesser M; Schneider PM
Recent Results Cancer Res; 2010; 182():93-106. PubMed ID: 20676874
[TBL] [Abstract][Full Text] [Related]
46. [Surgery for cancers at the esophagogastric junction and Barrett's esophageal cancers].
Shirakawa Y; Tanabe S; Noma K; Sakurama K; Fujiwara T
Nihon Rinsho; 2011 Aug; 69 Suppl 6():322-8. PubMed ID: 22471038
[No Abstract] [Full Text] [Related]
47. A Novel Valvuloplastic Esophagogastrostomy Technique for Laparoscopic Transhiatal Lower Esophagectomy and Proximal Gastrectomy for Siewert Type II Esophagogastric Junction Carcinoma-the Tri Double-Flap Hybrid Method.
Omori T; Yamamoto K; Yanagimoto Y; Shinno N; Sugimura K; Takahashi H; Yasui M; Wada H; Miyata H; Ohue M; Yano M; Sakon M
J Gastrointest Surg; 2021 Jan; 25(1):16-27. PubMed ID: 32157606
[TBL] [Abstract][Full Text] [Related]
48. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
[TBL] [Abstract][Full Text] [Related]
49. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
[TBL] [Abstract][Full Text] [Related]
50. Authors' reply: Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction (Br J Surg 2013; 100: 1050-1054).
Mine S; Sano T
Br J Surg; 2014 May; 101(6):735-6. PubMed ID: 24723024
[No Abstract] [Full Text] [Related]
51. Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients.
Imamura Y; Watanabe M; Toihata T; Takamatsu M; Kawachi H; Haraguchi I; Ogata Y; Yoshida N; Saeki H; Oki E; Taguchi K; Yamamoto M; Morita M; Mine S; Hiki N; Baba H; Sano T
Digestion; 2019; 99(1):6-13. PubMed ID: 30554205
[TBL] [Abstract][Full Text] [Related]
52. Esophageal intramural spreading from an adenocarcinoma of the esophagogastric junction.
Ikeda Y; Kurihara H; Niimi M; Kodaira S
Hepatogastroenterology; 2004; 51(59):1382-3. PubMed ID: 15362758
[TBL] [Abstract][Full Text] [Related]
53. [CT in differentiation of cT3 and cT4a Siewert type II esophagogastric junction adenocarcinoma: A comparison study based on UICC/AJCC 8th edition and IGCA 4th edition].
Fu J; Tang L; Li Z; Li X; Zhang Y; Gao S; Sun Y; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1013-1018. PubMed ID: 30269321
[TBL] [Abstract][Full Text] [Related]
54. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
[TBL] [Abstract][Full Text] [Related]
55. Adenocarcinoma in Barrett's esophagus following total resection of the gastric remnant: a case report.
Konishi M; Kato H; Tachimori Y; Watanabe H; Yamaguchi H; Ishikawa T; Itabashi M; Hirota T
Jpn J Clin Oncol; 1992 Aug; 22(4):292-6. PubMed ID: 1331573
[TBL] [Abstract][Full Text] [Related]
56. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction.
Yoshinaga S; Gotoda T; Kusano C; Oda I; Nakamura K; Takayanagi R
Gastrointest Endosc; 2008 Feb; 67(2):202-9. PubMed ID: 18226681
[TBL] [Abstract][Full Text] [Related]
57. [Dilemmas in definition and classification of adenocarcinoma of esophagogastric junction: from history to current status].
Chen L; Liu FL
Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):813-818. PubMed ID: 36058706
[TBL] [Abstract][Full Text] [Related]
58. Treatment approaches to esophagogastric junction tumors.
Kurokawa Y; Sasako M; Doki Y
Dig Surg; 2013; 30(2):169-73. PubMed ID: 23867594
[TBL] [Abstract][Full Text] [Related]
59. Tumor size predicts worse prognosis in esophagogastric junction adenocarcinoma.
Takeda FR; Ramos MFKP; Pereira MA; Sallum RAA; Ribeiro Junior U; Nahas SC; Cecconello I
Updates Surg; 2022 Dec; 74(6):1871-1879. PubMed ID: 35776245
[TBL] [Abstract][Full Text] [Related]
60. [Adenocarcinoma of the esophagogastric junction: diagnostic and surgical strategies].
Bruns CJ
Chirurg; 2012 Aug; 83(8):696-7. PubMed ID: 22878574
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
